958002-25-0 Usage
Uses
Used in Herbicide Synthesis:
tert-butyl N-isopropyl-N-methylsulfamoylcarbamate is used as an intermediate in the synthesis of Saflufenacil-d7 (S081802), which is a labeled version of the herbicide Saflufenacil (S081800). Saflufenacil belongs to the pyrimidinedione chemical class and is utilized for preplant burndown and selective preemergence dicot weed control in various field crops. Its mode of action involves the inhibition of the protoporphyrinogen IX oxidase (PPO) enzyme, which is essential for the growth and development of weeds.
Used in Agricultural Industry:
In the agricultural industry, tert-butyl N-isopropyl-N-methylsulfamoylcarbamate plays a crucial role in the development and production of Saflufenacil-d7, a herbicide that helps control dicot weeds in different field crops. This contributes to improved crop yields and reduced competition from weeds, ultimately benefiting farmers and the agricultural sector as a whole.
Check Digit Verification of cas no
The CAS Registry Mumber 958002-25-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,8,0,0 and 2 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 958002-25:
(8*9)+(7*5)+(6*8)+(5*0)+(4*0)+(3*2)+(2*2)+(1*5)=170
170 % 10 = 0
So 958002-25-0 is a valid CAS Registry Number.
958002-25-0Relevant academic research and scientific papers
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
-
Page/Page column 58, (2010/09/05)
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS
-
Page/Page column 71; 142-143, (2009/06/27)
The invention encompasses compounds of formula (I) as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV
Cyclopropyl Fused Indolobenzazepine HCV NS5B Inhibitors
-
Page/Page column 51-52, (2008/06/13)
The invention encompasses compounds of formula I as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and are useful in treating those infected with HCV.
